A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy

A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy

ObjectivesReal-time assessment of treatment response in glioblastoma (GBM) patients on immune checkpoint blockade (ICB) remains challenging because inflammatory effects of therapy may mimic progressive disease, and the temporal evolution of these inflammatory findings is poorly understood. We compar...

Full description

Bibliographic Details
Main Authors:	Xin Chen, Mary Jane Lim-Fat, Lei Qin, Angie Li, Annie Bryant, Camden P. Bay, Lu Gao, Nityanand Miskin, Zaiyi Liu, J. Bryan Iorgulescu, Xiaoyin Xu, David A. Reardon, Geoffrey S. Young
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Oncology
Subjects:	glioblastoma immunotherapy magnetic resonance imaging disease progression pseudoprogression response assessment in neuro-oncology criteria
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.679331/full

Similar Items

Evaluation of RANO Criteria for the Assessment of Tumor Progression for Lower-Grade Gliomas
by: Fabio Raman, et al.
Published: (2023-06-01)

Evaluation Of Surgical Resection for Recurrent Glioblastoma Using The RANO Classification For Extent Of Resection: A Report Of The RANO Resect Group
by: Philipp Karschnia, et al.
Published: (2023-01-01)

Evolution of RANO in Assessing Brain Tumour Outcomes
by: Qurat-ul-Ain Virani, et al.
Published: (2024-02-01)

The LUMIERE dataset: Longitudinal Glioblastoma MRI with expert RANO evaluation
by: Yannick Suter, et al.
Published: (2022-12-01)

RANO NEGATIVNO ISKUSTVO KAO REGULATOR REAKTIVNOSTI NA STRES
by: Milica Lazić, et al.
Published: (2015-07-01)

Prehranska podpora pri bolnikih s kronično rano in razjedo zaradi pritiska
by: Pavla Lavrinec, et al.
Published: (2007-09-01)

Response Assessment in Brain Metastases Managed by Stereotactic Radiosurgery: A Reappraisal of the RANO-BM Criteria
by: Keiss Douri, et al.
Published: (2023-10-01)

Koncepcia spravodlivej vojny v stredovekej a rano-novovekej sociálno-právnej filozofii
by: Peter Vyšný, et al.
Published: (2023-10-01)

Rano učenje engleskog jezika iz perspektive roditelja djece vrtićke i mlađe školske dobi
by: Mirna Erk, et al.
Published: (2022-01-01)

Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy - Detecting Illusive Disease, Defining Response
by: Raymond Yi-Kun Huang, et al.
Published: (2015-02-01)

Refinement of response assessment in neuro-oncology (RANO) using non-enhancing lesion type and contrast enhancement evolution pattern in IDH wild-type glioblastomas
by: Hye Hyeon Moon, et al.
Published: (2021-06-01)

The Role of Climate: 71 ka of Atmospheric Mercury Deposition in the Southern Hemisphere Recorded by Rano Aroi Mire, Easter Island (Chile)
by: Marta Pérez-Rodríguez, et al.
Published: (2018-10-01)

Unusual radiologic manifestation of pseudoprogression in pulmonary metastases after durvalumab treatment in metastatic bladder urothelial cancer
by: Eun Young Kim, et al.
Published: (2019-04-01)

«Dziś rano dostałam Twój kochany list, a już wieczorem odpisuję»: Felicja Trapszo-Krywultówna do Leonii Jabłonkówny 1930–1936
by: Grażyna Chmielewska
Published: (2018-06-01)

Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report
by: Amrit S. Gonugunta, et al.
Published: (2022-07-01)

The influence of endothelial hyperplasia on pseudoprogression development in patients with glioblastoma
by: Petrović Marko, et al.
Published: (2019-01-01)

Hyperprogressive Disease in Cancers Treated With Immune Checkpoint Inhibitors
by: Pan Shen, et al.
Published: (2021-07-01)

Incidence of Immune-Mediated Pseudoprogression of Lymphoma Treated with Immune Checkpoint Inhibitors: Systematic Review and Meta-Analysis
by: Amy Junghyun Lee, et al.
Published: (2021-05-01)

Pseudoprogression; discussion of the concept of pseudoprogression on the characteristics of tomographic changes in liver metastases of colorectal cancer patients receiving bevacizumab therapy
by: Pinar Ozdemir Akdur, et al.
Published: (2023-09-01)

The Potential Use of Radiomics with Pre-Radiation Therapy MR Imaging in Predicting Risk of Pseudoprogression in Glioblastoma Patients
by: Michael Baine, et al.
Published: (2021-01-01)

Machine Learning Model to Predict Pseudoprogression Versus Progression in Glioblastoma Using MRI: A Multi-Institutional Study (KROG 18-07)
by: Bum-Sup Jang, et al.
Published: (2020-09-01)

Pseudoprogression and hyperprogression secondary to immunotherapy in lung cancer
by: R. Riera-Sala, et al.
Published: (2023-09-01)

Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort studyResearch in context
by: Elizabeth Vera, et al.
Published: (2023-01-01)

UTEMELJUJUĆI DUHOVNI AUTORITET OSMANSKOG DRUŠTVA (Ahmed Zildžić: I prijatelj i neprijatelj: rano osmansko društvo i Ibn ‘Arabi, Orijentalni institut, Sarajevo, 2020)
by: Rusmir Šadić
Published: (2021-02-01)

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma
by: Julianna K. Bronk, et al.
Published: (2018-02-01)

Pseudo-progression with osimertinib after definitive chemoradiation in unresectable epidermal growth factor receptor mutation positive of stage III non-small cell lung cancer: A case report
by: Fei Ren, et al.
Published: (2022-08-01)

The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy
by: Wenxiao Jia, et al.
Published: (2019-12-01)

Pilot Study of CT-Based Radiomics Model for Early Evaluation of Response to Immunotherapy in Patients With Metastatic Melanoma
by: Zhi-long Wang, et al.
Published: (2020-08-01)

A Case of Pseudoprogression During Atezolizumab Therapy  in Lung Adenocarcinoma
by: Xue WANG, et al.
Published: (2019-06-01)

Pseudoprogression Disease in a Patient with Small Cell Lung Cancer on Immune Checkpoint Inhibitor Therapy
by: Zhu W, et al.
Published: (2023-09-01)

A case of pseudoprogression in avelumab maintenance therapy for metastatic bladder cancer
by: Nozomi Hayakawa, et al.
Published: (2023-01-01)

Radiomics-guided checkpoint inhibitor immunotherapy for precision medicine in cancer: A review for clinicians
by: Huijie Zhou, et al.
Published: (2023-03-01)

The Diagnosis and Treatment of Pseudoprogression, Radiation Necrosis and Brain Tumor Recurrence
by: Kashif Parvez, et al.
Published: (2014-07-01)

Dramatic response to pembrolizumab after pseudoprogression in a patient with advanced metastatic castration‐resistant prostate cancer
by: Takumi Kageyama, et al.
Published: (2022-11-01)

Impact of PTV margin reduction (2 mm to 0 mm) on pseudoprogression in stereotactic radiotherapy of solitary brain metastases
by: Justine Badloe, et al.
Published: (2021-03-01)

The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma
by: Jing Xi, et al.
Published: (2021-03-01)

PACS-Integrated Tools for Peritumoral Edema Volumetrics Provide Additional Information to RANO-BM-Based Assessment of Lung Cancer Brain Metastases after Stereotactic Radiotherapy: A Pilot Study
by: Manpreet Kaur, et al.
Published: (2023-09-01)

Differentiating tumour progression from pseudoprogression in glioblastoma patients: a monoexponential, biexponential, and stretched-exponential model-based DWI study
by: Dan Liao, et al.
Published: (2023-09-01)

Delayed pseudoprogression of a vestibular schwannoma postradiosurgery
by: Janna Malone, CCPA, et al.
Published: (2020-06-01)

Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series
by: Yongbo Xiang, et al.
Published: (2023-07-01)